Clinical study of Qinzhu Liangxue Decoction in the treatment of atopic dermatitis: a randomized controlled trial.
- Conditions
- atopic dermatitis
- Registration Number
- ITMCTR2000003981
- Lead Sponsor
- Yueyang Integrated Traditional Chinese and Western Medicine Hospital affiliated to Shanghai University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. According to the standard of TCM syndrome differentiation and Western medicine diagnosis;
2. The age ranged from 18 to 65 years old;
3. Those who agree to participate in clinical trial observation and can cooperate with regular follow-up;
4. Sign and date the informed consent form.
1. Systemic application of hormone or immunosuppressive drugs within two weeks;
2. Known to be allergic to any component of the study drug;
3. Any clinically significant laboratory test results considered by the researchers to have an impact on patient safety;
4. Pregnant women during pregnancy, lactation or planned trial period;
5. Patients with diabetes mellitus or severe heart, liver and kidney disease;
6. Those who have received other research drugs or participated in other clinical trials within 3 months;
7. Unable to cooperate with the research for any reason, such as language understanding, unable to go to the Research Center for treatment, etc;
8. Other conditions or diseases that researchers believe may bring obvious risks to patients or confuse the research results and should be excluded.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SCORAD score;
- Secondary Outcome Measures
Name Time Method DIQL score;